INS and Alzheimer disease: For the treatment of AD, researchers have investigated a number of receptors, including transferrin lactoferrin, insulin, low density lipoproteins, and toll-like receptors, in the hopes of delivering the drug moiety to the target region in the brain while avoiding the BBB (Wong et al., 2019).